The Impact of Intravenous Fluid Therapy on Acid-Base Status of Critically Ill Adults: A Stewart Approach-Based Perspective

Abstract

One of the most important tasks of physicians working in intensive care units (ICUs) is to arrange intravenous fluid therapy. The primary indications of the need for intravenous fluid therapy in ICUs are in cases of resuscitation, maintenance, or replacement, but we also load intravenous fluid for purposes such as fluid creep (including drug dilution and keeping venous lines patent) as well as nutrition. However, in doing so, some facts are ignored or overlooked, resulting in an acid-base disturbance. Regardless of the type and content of the fluid entering the body through an intravenous route, it may impair the acid-base balance depending on the rate, volume, and duration of the administration. The mechanism involved in acid-base disturbances induced by intravenous fluid therapy is easier to understand with the help of the physical-chemical approach proposed by Canadian physiologist, Peter Stewart. It is possible to establish a quantitative link between fluid therapy and acid–base disturbance using the Stewart principles. However, it is not possible to accomplish this with the traditional approach; moreover, it may not be noticed sometimes due to the normalization of pH or standard base excess induced by compensatory mechanisms. The clinical significance of fluid-induced acid-base disturbances has not been completely clarified yet. Nevertheless, as fluid therapy may be the cause of unexplained acid-base disorders that may lead to confusion and elicit unnecessary investigation, more attention must be paid to understand this issue. Therefore, the aim of this paper is to address the effects of different types of fluid therapies on acid-base balance using the simplified perspective of Stewart principles. Overall, the paper intends to help recognize fluid-induced acid-base disturbance through bedside evaluation and choose an appropriate fluid by considering the acid-base status of a patient.

Introduction

Intravenous fluid therapy is a standard part of intensive care management, and has been shown to impact the acid-base status of a patient. Historically, the origin of fluid-associated acid-base disorders is based on the recognition of complex metabolic acid-base disorders that occur after performing different infusion regimens, particularly with the development of intensive care medicine. The most typical example of an acid-base disorder is saline-related hyperchloremic acidosis. In addition, for the mechanistic explanation of complex acid-base disturbances induced by different fluid types, the Stewart approach is superior to the traditional approach.1

According to their similarity to plasma, fluid regimes can be broadly categorized as balanced and unbalanced in terms of the ionic composition of the fluid. Current data have shown that resuscitation with unbalanced fluids is associated with the risk of acidosis, whereas the acid-base balance is better preserved with the use of balanced fluids. However, the vast majority of such data were obtained from shock and perioperative cases in which high-volume fluids were rapidly given and analyzed with the traditional approach. In contrast to the roughly defined relationship established with the traditional approach, by using the simplified Stewart method for bedside evaluation, we can predict and quantify the effects of individual commercially available fluids on acid-base balance. Therefore, fine adjustment can be made on fluid management to optimize the acid-base status of critically ill patients who are under the risk of developing fluid-induced acid-base disorders.

Stewart Perspective

According to the Stewart model, there are three independent factors that determine the acid-base balance. Of the three factors, the arterial carbon dioxide tension (PaCO₂) determines the respiratory component of the acid-base balance, while the two described below determine the metabolic component:

• 1) Strong ion difference (SID): The difference between the total concentration of strong cations and strong anions, represented as ([sodium]+[potassium]+[calcium]+[magnesium]+[others, including lithium+aluminium, etc.]) − ([chloride]+[lactate]+[others, including ketone +acetate+sulfate, etc.]), which is simply [sodium] – [chloride] (Figure 1A and B).

• 2) Total weak acid concentration (A_TOT): This is mainly the concentration of albumin and inorganic phosphate.

Figure 1.

Simplified illustration of normal acid-base status and metabolic acid-base disturbances with gamblegrams based on the Stewart approach. (A–B) Normal states: As a result of the electroneutrality law, the concentration of total cations is equal to that of total anions. While strong ions dissolve in water completely, weak ions only dissolve partially. There are two major strong ions in the ECF—[Na] as the cation and [Cl] as the anion. Strong cations besides [Na], such as [K], [Ca], [Mg], [Li], [Al], and others, are represented as OC. Moreover, OA represents other strong anions besides Cl and lactate. OA contains strong anions, including ketone, sulfate, acetate, and others. The difference between all strong cations and all strong anions is known as [SID]. Since Na and Cl are the principal ions of the ECF,[SID] can be simplified as the difference between Na and Cl. In order to preserve electroneutrality, [A _TOT] and [HCO₃] fill the space formed by the SID. SIDa is simply calculated as Na–(Cl+Lactate), and SIDe is the sum of A⁻ + HCO₃. A⁻ is the dissociated part of A_TOT that indicates [Alb⁻]+ [Pi⁻]. Additionally, SIG is the difference between SIDa and SIDe. Notably, while SIDa is a calculated parameter, SIDe is a measured one. OA also represents SIG. (C) The reduced SID due to water surplus or sodium loss. (D) Hyperchloremic acidosis: SID is narrowed due to the presence of excess chloride. (E) Hypernatremic alkalosis: SID is widened due to sodium surplus or water loss. (F) Hypochloremic alkalosis: SID is increased due to chloride loss. (G) Increased [A_TOT] due to hyperphosphatemia or hyperalbuminemia squeezes [HCO3] and, subsequently, acidosis. (H) Hypoalbuminemia or hypophosphatemia widened [HCO3] with a decrease in [A _TOT], resulting in alkalosis. (I) Lactic acidosis: Lactate is considered a strong anion that decreases SID upon accumulation; SIG acidosis; eg, ketoacidosis.

Abbreviations: mEq/L, milli equivalent per liter; OC, other cations; OA, other anions; ECF, extracellular fluid; [SID], strong ion difference; [SIDa], apparent SID; [SIDe], effective SID; [SIG], strong ion gap; AG, anion gap; [A_TOT], total weak acid concentration; [Na], sodium; [K], potassium; [Li], lithium; [Ca], calcium; [Al], aluminium; [HCO₃], bicarbonate; [Cl], chloride; [Alb], albumin; [Pi], inorganic phosphate.

As the influence of fluid therapy on acid-base balance involves the metabolic component,1 the respiratory component is beyond the scope of this review.

In normal states, SID corresponding to the difference between sodium and chloride concentration is approximately 40 mEq/L within limits of 38 and 42 mEq/L.2,3 As illustrated with the gamblegrams in Figure 1, when SID is narrowed in the case of either sodium decrease or chloride increase, it results in acidosis (Figure 1C and D).4 However, SID can be widened in the case of hypernatremia (eg, infusion of sodium bicarbonate) or by hypochloremia (eg, loss of chloride due to vomiting or loop diuretics.) (Figure 1E–F). Elevated levels of other anions also lead to acidosis (ie, lactic acidosis and ketoacidosis) due to a decrease in SID (Figure 1I).4 Additionally, A_TOT is the third variable that can cause independent variations in the pH level. The approximate amount of A_TOT is calculated using the following equation:

2.5 x albumin (g/dL) + 0.6 x phosphate (mg/dL)

Here, the coefficients in front of albumin and phosphate are the mEq/L equivalents of the electrical charge that each generates for each one gram of albumin per deciliter and one milligram of phosphate per deciliter when dissolved in plasma. If phosphate is given in mmol/L, then it will be multiplied by 1.5.5–7 The mid-reference valuesare10 mEq/L and 2 mEq/L for albumin and inorganic phosphate, respectively.5,7 An increase in A_TOT is associated with acidosis, whereas its decrease results in alkalosis. This increase can be caused by high levels of phosphates, which occurs during renal failure. On the other hand, typically, a reduction in A_TOT is due to low concentrations of albumin (Figure 1G–H).4,8,9

A_TOT is principally composed of albumin. In the majority of long-term critically ill patients, hypoalbuminemia is observed due to reasons such as volume overload, endothelial leak due to inflammation, and nutritional deficiency.4,10 Although hypoalbuminemic alkalosis seems to prevent acidosis, it is actually not true. Moreover, as a compensatory response, low A_TOT and high pH stimulate Cl retention, which subsequently decreases SID.11 Most critically ill patients only have a very mild alkalosis (if at all) and a low SID to compensate for the low A_TOT. Lower SID means that they can tolerate an acid load less well.

The contribution of inorganic phosphate is relatively low and mostly neglected, except in the case of hyperphosphatemic acidosis, which may be significant in renal failure.5,11 Apart from these independent parameters, another concept has been proposed by the Stewart model—strong ion gap (SIG). In order to define SIG, it is necessary to know about its relationships with the anion gap and SID. Since, in the past, the concentrations of albumin, phosphate, lactate, ketone, sulfate, citrate, acetate, and others could not be measured in the laboratory, the number of these unmeasurable anions was determined by subtracting measurable anions from measurable cations, assigning a value known as the anion gap (AG).12 On the other hand, SIG is the total concentration of the remaining unmeasured anions other than albumin, phosphate, and lactate that constitute the main components of AG.5,8,13,14 In other words, SIG is equal to anion gap – (lactate + A_TOT). As can be seen, the term “unmeasured” is quite a misnomer. Although measurable in modern times, since they (eg, ketone) are not included in the anion gap calculation, they are still referred to as unmeasured. Therefore, both AG and SIG quantify unmeasured anion concentration. However, unlike AG, SIG is not affected by a change in albumin concentration, and thus, it does not require correction for the albumin.14

Moreover, SIG can be explained in terms of its relationship with SID. SIG is equal to the difference between the apparent SID (SIDa) and the effective SID (SIDe). SIDa is the electrical gap between strong cations and strong anions, which is formulated as ([Na⁺]+[K⁺]+[Ca⁺⁺]+[Mg⁺⁺]) – ([Cl]+[Lactate]+[Urate]) but simply as ([Na]) – ([Cl]+[Lactate]). SIDe is the anionic charge filling this gap, which is determined as[A⁻]+[HCO₃⁻]. [A⁻] represents the dissociated form of A_TOT(Figure 1B). Conceptually, SIDa is equal to SIDe, as required by the electroneutrality law. In the case of increased unmeasured anions or SIG, SIDa increases but not SIDe.14 Based on the equation SIG=SIDa – SIDe, a marked deviation from zero should suggest an increase of unknown ions in the body.

No standard range for SIG has been mentioned in the literature. It is expected to be below 2 mEq/L,15 but in most studies, it was determined to be approximately 5 mEq/L for intensive care unit (ICU) patients.16–18

Physiopathology of Fluid-Related Acid-Base Disturbances

Fluid-induced acid-base disturbances can be mechanistically explained as follows. The SID of each fluid is different from the plasma. If an excessive amount of fluid is rapidly delivered through an intravenous route, the plasma SID moves toward the SID of the fluid after infusion; hence, based on the alteration of SID, the acid-base balance may be disturbed.1,19-21

The rate and dosage of the fluid are crucial for causing post-infusion change to the SID. It is best documented in the case of the administration of crystalloids up to 70 mL/kg/h for two hours for intraoperative fluid replacement.22 Within the infusion period, the strong ions in the infusate (eg, Na⁺, K⁺, Mg⁺⁺, Ca⁺⁺, Cl⁻, lactate, and acetate) fill the extracellular fluid compartment, changing the ion balance of the plasma.21,23 As the plasma undergoes hemodilution, the SID will change linearly.19 In this context, for instance, in the saline-induced hyperchloremic acidosis, the mechanism is not the dilutional reduction of bicarbonate but the narrowing of the plasma SID after dilution with zero SID,1 and change in bicarbonate concentration is only a consequence.

Concurrent volume increase with fluid therapy leads to dilution of A_TOT and the alkalotic effect.20 If this dilutional effect is accompanied by increased SID, alkalosis further increases but due to reduced SID, alleviating acidosis. Fluids with weak acid content such as albumin, phosphate, or gelatine have acidosis potential due to the A_TOT activity.1,25 Experimental studies have shown that SID should be 24 mEq/L for a solution to not affect the acid-base balance in healthy conditions.19,24,25 In view of this finding, it can be asserted that the fluid SID should be equal to the bicarbonate concentration in the patient to prevent a change in pH when the plasma is mixed with fluids. As a result, if it is lower than the bicarbonate value of the patient, the tendency to develop acidosis may be generated, and vice versa for alkalosis.19,26,27

According to the electroneutrality law, the in-vitro SID of all fluids (SID in a bag) is zero. However, when the fluids called balanced crystalloids are mixed with the plasma, the anions, such as lactate, gluconate, acetate, or malate, are eliminated by converting them to bicarbonate. Due to this gap, the in-vivo SID becomes higher than zero. Thus, in order to predict the iatrogenic effects of fluids on acid-base balance, we need to know their ionic composition and the in vivo SID values. A detailed list of some commercially available balanced and unbalanced fluids has been provided in Table 1.

Table 1.

Some Examples of Commonly Known Fluids with Their Composition and SID Values

	Strong Cations mEq/L				Strong Anions mEq/L			ATOT mEq/L			SID mEq/L
	Na+	K+	Ca++	Mg++	Cl-	Lactate	OA	Alb	Pi	OWA	SID in vitro	SID in vivo
Unbalanced Fluidsa
Dextrose 5% in Water (D5W)	0	0	0	0	0	0	0	0	0	0	0	0
NaCl 0.45% / D5W (1/2 NS)	77	0	77	0	0	0	0	0	0	0	0	0
NaCl0.9% (NS)	154	0	0	0	154	0	0	0	0	0	0	0
Ringer’s solution	147	4	4.5	0	155.5	0	0	0	0	0	0	0
NaCl 3%	512	0	0	0	512	0	0	0	0	0	0	0
Mannitol 20%	0	0	0	0	0	0	0	0	0	0	0	0
6% HES (130/0.4) in NS	154	0	0	0	154	0	0	0	0	0	0	0
Dextran70 6% in D5W	0	0	0	0	0	0	0	0	0	0	0	0
Balanced Fluidsb
Ringer’s Lactate (RL)	131	5.4	4	0	111	29	0	0	0	0	0	29
Ringer’s Acetate (RA)	130	5.4	1.8	2	112	0	27acetate	0	0	0	0	27
Ringer ‘s Fundin (RF)	145	4	5	2	127	0	24 acetate 5 malate	0	0	0	0	29
Plasmalyte	140	5	0	3	98	0	27 acetate 23 gluconate	0	0	0	0	50
Sodium bicarbonate 8.4%	1000	0	0	0	0	0	1000 HCO3	0	0	0	0	1000
Albumin 20%c	125	<2	<4	0	80	0	0	50	0	0	0	~51
Albumin 4%	140	0	0	0	128	0	0	10	0	0	0	12
6% HES (130/0.4) in a balanced fluid	137	4	0	3	110	0	34 acetate	0	0	0	0	34
Succinylated gelatine 4%	154	0	0	0	120	0	0	0	0	40 g/L Succinylated gelatine	0	34
Polygeline 3.5%	145	5.1	12.5	0	145	0	0	0	0	35 g/L urea linked gelatine	0	17.6

Notes: All concentrations are given in mEq/L except for other weak acids in g/L. 6%HES (130/0.4) in NS (^® Voluven) by Fresenius Kabi, Bad Homburg, Germany. ^bThere are slightly different formulations available based on the manufacturer. Ringer’s Fundin (^®Sterofundin ISO) by B. Braun Melsungen AG, Melsungen, Germany. Plasmalyte (^®Plasmalyte 148) by Baxter, Deerfield, Illinois, United States of America. Albumin 4% (^®Albumex 4) by CSL Behring, Broadmeadows, Victoria, Australia. 6%HES (130/0.4) in a balanced fluid (^®Volulyte by Fresenius Kabi, Bad Homburg, Germany. Succinylated gelatine 4% (^®Gelofusine) by B. Braun Melsungen AG, Melsungen, Germany. Polygeline 3.5% (^®Haemaccel) by Piramal Healthcare, Northumberland, United Kingdom. ^cInformation based on Bruegger et al.28.

Abbreviations: OWA, other weak acids; Pi, inorganic phosphate; OA, other anions; SID, strong ion difference; NS, normal saline; HES, hydroxyethyl starch.

Quantification of Fluid Effect on Acid-Base Balance

Prior to the Stewart model, researchers following the traditional approach developed standard bicarbonate, base excess, and standard base excess (SBE) to isolate the metabolic component from the compensatory effects of the respiratory component.29–34 Of these, the most widely accepted and recommended tool for clinical use is the SBE.35–37 SBE is defined as the amount of acid or base to return in vitro one-liter extracellular fluid to normal pH (7.40) under standard conditions (at 37°C at a PaCO₂ of 40 mmHg). It ranges from −3 to +3 mEq/L.

Non-normal negative values indicate acidosis, while positive values indicate alkalosis. It is considered that a patient with an SBE of –8 mEq/L has an excess of 8 mEq of acid per liter of extracellular fluid. Therefore, it is assumed that 8 mEq sodium bicarbonate per liter of extracellular fluid will be needed to neutralize acidosis. Extracellular fluid accounts for approximately 30% of the body fluid; therefore, we can estimate the total required dose of sodium bicarbonate. We can apply the same estimation for the conceptual dose of hydrochloric acid for alkalosis with an SBE of +8 mEq/L.

SBE helps quantify the amount of metabolic acid-base disorder but does not differentiate the causative pathologies. In response to this question, in the research studies, the Stewart principles were simplified, and the components of acid-base disorder could be individually displayed with their corresponding quantitative contributions.5,38-40

Accordingly, the components of SBE and their quantitative effects are claimed to be as follows:

• 1) Chronic respiratory changes contribute as (PaCO₂−40)x0.4 mEq/L, but acute respiratory changes have no effect on SBE.34

• 2) The change in the difference between sodium and chloride concentration contributes as (Na−Cl)−38 mEq/L.

• 3) The change in A_TOT, mainly of albumin concentration, contributes as (4−albumin in g/dL) ⅹ 2.5 mEq/L.

• 4) The change in lactate contributes as (1−lactate) mEq/L.

• 5) The SIG effect as itself in mEq/L.

Note that the mid-reference values taken for lactate and albumin are 1 mEq/L and 4 g/dL, respectively. To better understand the methodology, we can examine a hypothetical case where pH=7.38, PaCO₂=25 mmHg, sodium=150 mEq/L, chloride =102 mEq/L, albumin=2 g/dL, lactate=6 mEq/L, and SBE=0 mEq/L.

In this case, there seems no metabolic acid-base disturbance according to SBE; however, if we analyze according to the Stewart principles, we obtain the following results:

• 1) (25−40)x0.4= −6 mEq/L; acidosis response to chronic respiratory alkalosis.

• 2) (48–38)= +10 mEq/L; hypernatremic alkalosis

• 3) (4−2)x2.5 = +5 mEq/L; hypoalbuminemic alkalosis

• 4) (1−6) = −5 mEq/L; lactic acidosis.

Assuming that the sum of the above ionic charge is equal to SBE, it can be inferred that the alkalosis of +4 mEq/L is offset by the SIG of −4 mEq/L. If the respiratory change was acute, alkalosis of +10 mEq/L would be offset by the SIG of −10 mEq/L to reach an SBE of 0 mEq/L.

The effect of the post-infusion change in A_TOT, SID, and SIG on acid-base balance can be estimated using this methodology.

Fluid Type

Broadly, fluids can be divided into two categories according to their ionic composition: balanced and unbalanced fluids. The term “balanced fluids” refers to intravenous solutions whose electrolyte composition is closer to the composition of plasma, as compared to previously available solutions, such as normal saline. Thus, balanced solutions should minimally affect the acid-base equilibrium. However, more recently, researchers have started to employ the term “balanced solution” to also indicate intravenous solutions with low chloride content.41,42 Fluids with electrolyte content outside the physiological limits compared to normal plasma are considered as unbalanced fluids. The SID of all unbalanced fluids is zero, whereas that of balanced fluids is greater than zero.

Unbalanced Fluids

The most widely used unbalanced fluid is normal saline (0.9% NaCl) for either resuscitation or drug dilution. Normal saline has zero SID and contains a supraphysiologic amount of sodium—154 mEq/L—and chloride—154 mEq/L—as compared to plasma. After an IV infusion of normal saline in a large volume, the increase in chloride will be higher than that in sodium. Inevitably, hyperchloremic acidosis will develop with a decrease in SID. However, in the case of neutral pH, due to superimposed alkalotic conditions, acidosis may not be recognized. This hidden condition can be revealed by calculating SID; if SID decreases tending toward below 40 mEq/L, acidosis develops. However, acidosis may be without hyperchloremia. All saline (not just 0.9%) and dextrose solutions have a SID of zero and will result in acidosis. For example, 0.45% saline has exactly the same effect as 0.9% saline does. The only difference is that Na falls more than Cl for 0.45% saline, whereas Cl increases more than Na for 0.9% saline. However, the effect on SID is the same.43 Hypertonic saline and mannitol produce the same effect on the acid-base balance due to zero SID but with the further dilution of hypertonicity, it further reduces the SID.44

Hydroxyethyl starch and dextran solutions are unbalanced colloids acting on acid-base balance through the in-vivo SID of the carrier fluid. As expected, all colloids in this category will show acidotic effect due to zero SID of the carrier fluid.25

Balanced Fluids

Although there are many commercially available balanced crystalloid fluids, the ones most commonly used are Ringer’s lactate and Plasmalyte, only varying in terms of the type and number of anions called bicarbonate precursors. The in-vitro SID of Ringer’s lactate bag is 0, and it contains 29 mEq/L of lactate. However, after infusion, lactate disappears upon conversion to bicarbonate. In vivo, the SID of the fluid rises from 0 to 29 mEq/L. Likewise, Plasmalyte contains 50 mEq/L of anions composed of 23 mEq acetate per liter and 27 mEq gluconate per liter serving as buffers, generating an in-vivo SID of 50 mEq/L. Actually, lactate, gluconate, acetate, and malate do not convert to bicarbonates. They go right into the Krebs cycle and are ultimately metabolized. Moreover, bicarbonate increases (from CO2) due to an increase in SID.

The higher the in-vivo SID value of the fluid, the more it creates the tendency toward alkalosis. Therefore, they can be a good option to neutralize or prevent fluid-related acidosis.

However, there are some limitations to using balanced fluids. Firstly, in the presence of liver dysfunction, oliguric renal dysfunction, hyperkalemia, and brain damage, they should be used cautiously. Secondly, the fact that these fluids cannot be used for drug dilution is also a limitation. However, it is worth mentioning that in two randomized trials that compared Ringer’s lactate and normal saline during renal transplantation, less hyperkalemia was observed in the former group.45,46 This effect is thought to be caused by a potassium shift out of the cell caused by acidosis, which developed more in the saline group. As with most balanced fluids, a small amount of potassium, such as 5 mEq/L, can be found in Ringer’s lactate, which is not thought to be as risky as hyperkalemia induced by acidosis. In the case of hepatic insufficiency, Ringer’s lactate may cause lactic acidosis, since lactate clearance is reduced.

There are two prototypes of balanced colloid fluids—human albumin solutions and gelatine preparations. Since these colloids are suspended in a balanced crystalloid solution, they are expected to produce a neutral or alkalotic effect, depending on the SID of the carrier fluid. However, they also have an acidic effect due to their respective A_TOT activity. As a result of this dual effect, they carry much less acidosis potential than unbalanced colloids. The effect of change in albumin concentration on acid-base balance can be quantified, whereas it is not clear for gelatin.

Total Parenteral Nutrition Solutions

There are two well-known groups of commercially available products of total parenteral nutrition (TPN) solutions. These are ready-to-use and pre-filled solutions with three unmixed chambers containing amino acids with electrolytes, lipids, and dextrose (Table 2).

Table 2.

Some TPN Solutions with Their Composition and SID Values

	Strong Cations mEq/L				Strong Anions mEq/L			ATOT mEq/L			SID mEq/L
	Na+	K+	Ca++	Mg++	Cl−	Lactate	OA	Alb	Pi	OWA	SID in vitro	SID in vivo
TPN triple bag solutionsa
Fresenius Kabi formulation for central veinb	31	23	3.8	7.8	45	0	38 acetate 7.8 sulfate	0	9.7	0	0	12.8
Fresenius Kabi formulation for central or peripheral veinb	22	17	2.8	5.6	32	0	27 acetate 5.6 sulfate	0	7.5	0	0	9.8
Baxter formulation for central veinc	32	24	4	4.4	48	0	57 acetate	0	10	0	0	16.4
Baxter formulation for central or peripheral veinc	21	16	4	4.4	33	0	30 acetate	0	8.5	0	0	15.4

Notes: All concentrations are given in mEq/L except for other weak acids in g/L. ^aFresenius Kabi formulations are with lipid content of purified soybean oil. Baxter formulations are with lipid content of olive oil (80%) and soybean oil (20%) mixture. Information from the package leaflet. ^b®Kabiven for central vein. All pack sizes have the same SID. ^®Perikabiven for central or peripheral vein. All pack sizes have the same SID. ^c®Olicnomel N7 for central vein. All pack sizes have the same SID. ^®Olicnomel N4 for central or peripheral vein. All pack sizes have the same SID.

Abbreviations: OWA, other weak acids; Pi, inorganic phosphate; OA, other anions; SID, strong ion difference; NS, normal saline; HES, hydroxyethyl starch.

Triple bag TPN solutions vary with their lipid content and can be categorized into two groups—one group with purified soybean oil and the other with a mixture of refined olive oil (80%) and refined soybean oil (20%). The electrolyte content of both is predominantly chloride-based, with SID ranging from 9.8 to 16.4 mEq/L. TPN solutions also have an A_TOT impact on phosphate content. They may accumulate particularly in patients with renal insufficiency and lead to hyperphosphatemic acidosis.

The group with purified soybean oil carries the risk of acidosis in another way: sulfate, another strong ion in its content, can accumulate in the case of renal failure and cause acidosis by reducing SID such as lactate. The amount of possible acidosis due to sulfate can be estimated by calculating SIG.

Additionally, since thiamine is the cofactor of the enzyme pyruvate dehydrogenase, which helps convert lactate to pyruvic acid in patients with long-term thiamine-free TPN, lactic acidosis may occur due to impaired lactate metabolism.47

Hyperchloremia and Hyperchloremic Acidosis

Chloride and sodium are the two main strong ions of extracellular fluid. However, the clinical effects of chloride, especially in relation to ICU, have been subjected to research in recent years, much later than that of sodium. While fluid-related chloride disorder is mostly presented as hyperchloremia or hyperchloremic acidosis,48 hypochloremia and/or hypochloremic alkalosis is mostly associated with diuretic therapy rather than fluid.49,50 Hyperchloremia caused by underlying diseases or fluid therapy is common in ICUs, within 25–45%.51–53 Saline-induced hyperchloremia does not seem to have a negative impact on the clinical outcomes of patients with normal acid-base balance and renal function prior to surgery.23 However, it is still unclear for critically ill patients mostly having reduced host reserve, multiorgan failure, and acid-base disturbance.23

It is common to confuse hyperchloremia with hyperchloremic acidosis. Although there is no clear limit for diagnosing hyperchloremia, the most commonly accepted one is [Cl] >110 mEq/L.42,54-56 When hyperchloremia is associated with acidosis, then it is called hyperchloremic acidosis. Considering the Stewart paradigm, the difference between sodium and chloride should be narrowed, instead of increasing chloride concentration to determine whether hyperchloremia is the source of acidosis.57 Suppose there are two patients, one with sodium and chloride concentrations of 135 and 112 mEq/L, respectively, and the other with 155 and 115 mEq/L, respectively. The first patient has hyperchloremic acidosis due to the acidic SID (23 mEq/L), while despite a higher chloride concentration, the second patient only has hyperchloremia due to normal SID (40 mEq/L). We can interpret the latter scenario to be a balancing effect of hypernatremic alkalosis against hyperchloremic acidosis.

Consistent with this paradigm, although Ringer’s lactate and Ringer’s fundin are chloride-liberal fluids in terms of chloride content (112 and 127 mEq/L, respectively), theoretically, both are expected to cause hyperchloremia without acidosis, as the SID for both is 29 mEq/L.

The most well-known fluid associated with hyperchloremic acidosis is normal saline. However, it should be emphasized that fluid-associated acidosis can be without hyperchloremia or with hypochloremia.57,58 Consider a healthy individual with 140 mEq/L of sodium and 100 mEq/L of chloride. Theoretically assuming that this person’s plasma is diluted with an equal amount of water, sodium concentration will drop to 70 mEq/L and chloride to 50 mEq/L. A decrease in the SID from 40 to 20 mEq/L results in acidosis. In this case, it might be interpreted that hypochloremic alkalosis is being suppressed by hyponatremic acidosis.

One of the most impressive examples of fluid-induced hyperchloremic acidosis in practice is observed during the treatment of diabetic ketoacidosis. According to the current guidelines, normal saline and 1/2 normal saline are recommended for the treatment of diabetic ketoacidosis.59 Since both fluids have zero SID, although ketoacidosis improves after the patient is hydrated with a large volume of these fluids, metabolic acidosis persists due to fluid-induced hyperchloremic acidosis. Balanced crystalloids can be thought to be used as a replacement of these fluids to overcome this complication. This putative benefit is supported by two studies that compared fluid resuscitation with Plasmalyte and normal saline in diabetic ketoacidosis. Hyperchloremia was observed in the saline-treated group, whereas in the Plasmalyte group, faster recovery of metabolic acidosis was observed and hyperchloremic acidosis was prevented.60,61

However, the same effect could not be demonstrated in the statistical significance for Ringer’s lactate in comparison with normal saline.62

Literary Data

There are an ample number of studies in the literature reporting data associated with fluid therapy for acid-base disturbances. Besides two large meta-analyses,63,64 preclinical65–68 and clinical22,45,46,60-62,69–76 studies, comparing different fluids on the basis of two main categories of balanced and unbalanced fluids, confirmed that while more acidosis was observed for the latter category, the acid-base balance was better maintained in the former category.

However, there are several gaps in this field of literature. First, there is almost no major randomized controlled trial (RCT) dealing primarily with the effects of fluids on acid-base balance. The current evidence of fluid-related acid-base disturbances is based on experimental studies, small-scale, mostly single-center RCTs, reviews, and meta-analyses. Moreover, in these studies, the effects of fluid therapy on acid-base balance are presented as a part of the secondary outcome rather than being the primary point of investigation.22,45,46,60–76

Second, although there are several studies that use the Stewart model, the majority of the data from the remaining were reported according to the interpretation of pH, SBE, chloride, and bicarbonate values, which fall within the scope of the traditional approach.

Third, there is no study investigating the influence of TPN solutions on acid-base balance through the Stewart perspective. Moreover, available data on TPN solutions are limited to a few studies.77–80 It is revealed that TPN solutions may the cause of metabolic acidosis that is thought to be a result of excess hydrogen burden resulting from the metabolism of amino acids and nitrogen sources in its content according to the traditional approach.77–80

Fourth, the risk of hyperkalemia is a common concern, which leads to avoiding balanced fluids and choosing normal saline. In contrast, studies have shown that both lactate Ringer and Plasmalyte develop less hyperkalemia than normal saline.45,46,81 However, these studies are limited only to patients undergoing renal transplantation. In order to clarify this concern, a more wide variety of well-designed studies is needed.

Finally, most of the available data are based on the effects of the fluids given in extreme doses for initial resuscitation in both surgical and non-surgical critical settings. However, the volume change due to non-resuscitation fluids is much more than in the case of resuscitation.82,83 Studies investigating the effects of cumulative fluid intake in long-term critically ill patients should also be conducted.

Conclusion

Theoretically, the Stewart approach helps not only in understanding the mechanisms of fluid-associated acid-base disorders but also in tailoring appropriate fluid therapy according to patient acid-base status. The clinical significance of fluid-induced acid-base disturbance has not been completely clarified yet. Nevertheless, since fluid therapy may be the source of unexplained acid-base disorder, probably causing confusion and eliciting unnecessary investigation, more attention should be paid to this issue. Analytical calculations using the Stewart method may be useful, as some disturbances may be hidden in conditions with normal pH or SBE. Moreover, the relationship between fluid therapy and acid-base balance needs to be demonstrated in a more rational way. Therefore, more powerful and high quality studies are needed, which take into account the above-mentioned gaps in the literature.

Funding Statement

There is no funding to report.

Disclosure

The authors report no conflicts of interest in this work.